Publication
Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associated with disease-free survival.
Anna-Jasmina Donaubauer, Oliver Tomic, Lia Mogge, Sarina K Müller, Cecilia Marie Futsaether, Kristian Hovde Liland, Bao Ngoc Huynh, Jens von der Grün, Panagiotis Balermpas, Max Fleischmann, Matthias G Hautmann, Felix Steger, Christopher Bohr, Thomas Hehr, Carmen Stromberger, Volker Budach, Markus Schymalla, Rita Engenhart-Cabillic, Lukas Kocik, Hans Geinitz, Ursula Nestle, Gunter Klautke, Claudia Scherl, Philipp Schubert, Stefanie Corradini, Rainer Fietkau, Udo S Gaipl, Benjamin Frey, Marlen Haderlein
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Immunological biomarkers are increasingly relevant for personalized cancer treatment, but peripheral blood-derived biomarkers are not yet used to guide therapy in head and neck squamous cell carcinoma (HNSCC). The prospective non-randomized DIREKHT study (ClinicalTrials.gov: NCT02528955,…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT02528955registry_reference1.00
Registered trialsNCT02528955
Curated evidence
Evidence citing this paper (0)
Data not yet available